Dr. Hanid Audish, DO: Family Physician and Clinical Research Investigator in Spring Valley, CA

About Dr. Hanid Audish, DO

Dr. Hanid Audish, DO, is a board-certified family medicine physician and clinical research investigator in Spring Valley, California, in San Diego County's East County. He is the Director, Principal Investigator, and physician owner of Encompass Clinical Research, an independent, multi-therapeutic research site that conducts Phase II–IV clinical trials for pharmaceutical and biotechnology sponsors.

Dr. Audish holds a Doctor of Osteopathic Medicine (DO) degree, not an MD. He earned it in 2004 from the College of Osteopathic Medicine of the Pacific at Western University of Health Sciences. He completed his internship at Doctors' Hospital Medical Center of Montclair and his family medicine residency at Downey Regional. He is board-certified in family medicine by the American Osteopathic Board of Family Physicians (AOBFP), and he is affiliated with Sharp Grossmont Hospital in La Mesa. Dr. Audish speaks English and Arabic.

Dr. Audish has practiced family medicine in Spring Valley. Family medicine means caring for the whole person across many conditions and life stages, and that background informs his work as an investigator, where participant safety and informed consent come first.

Encompass Clinical Research was founded by Robert S. Lipetz, DO. According to the company, the site has completed more than 500 studies with more than 8,000 participants. ClinicalTrials.gov lists Encompass Clinical Research as a study location on more than 100 registered trials. Sponsors include Eli Lilly, Pfizer, AstraZeneca, Shire, and Roche. The trials cover obesity, type 2 diabetes, cardiovascular and metabolic disease, gout, vaccines, and other areas.

Encompass has served as a participating study site in several of the most widely cited trials in metabolic medicine, including STEP 1 (semaglutide for obesity), the SURMOUNT program (tirzepatide for obesity), the SELECT cardiovascular-outcomes trial, and studies of once-weekly insulin efsitora and oral orforglipron. Dr. Audish is credited as a site investigator in the published investigator lists for these trials in The New England Journal of Medicine, The Lancet, and JAMA Cardiology. These are large multinational studies with many sites and investigators, and his role was to lead the work at the Spring Valley site.

At Encompass, Dr. Audish leads a team that includes an office manager, clinical research coordinators, participant recruiters, and a registered dietitian. Together they handle each study from start-up through close-out: screening and enrolling volunteers, running protocol visits, and reporting data to sponsors. As of October 2026, ClinicalTrials.gov lists Dr. Audish on studies that are currently recruiting. These include trials of eloralintide, an investigational Eli Lilly medicine, in adults with obesity or overweight and type 2 diabetes, and in adults with knee osteoarthritis pain and obesity or overweight. They also include studies comparing dotinurad with allopurinol in people with gout.

Because Encompass is based in East County, local adults can take part in clinical research close to home, under the supervision of a physician investigator.

At a glance

• Credential: DO (Doctor of Osteopathic Medicine), Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, 2004
• Board certification: Family Medicine, American Osteopathic Board of Family Physicians
• Postgraduate training: Internship, Doctors' Hospital Medical Center of Montclair; Family Medicine Residency, Downey Regional
• Current role: Director, Principal Investigator, and physician owner, Encompass Clinical Research, Spring Valley, CA
• Hospital affiliation: Sharp Grossmont Hospital, La Mesa, CA
• Languages: English, Arabic
• NPI: 1598975690

Research & Publications

Dr. Audish is credited as a study investigator (part of the trial's investigator group, not a byline author) on the following peer-reviewed publications. These are reports from multicenter trials in which Encompass Clinical Research took part as a study site.

• Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021. PubMed · DOI
• Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022. PubMed · DOI
• Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023. PubMed · DOI
• Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. Lancet. 2024. PubMed · DOI
• Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med. 2025. PubMed · DOI
• Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy. N Engl J Med. 2025. PubMed · DOI
• Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine. N Engl J Med. 2025. PubMed · DOI
• Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial. JAMA Cardiol. 2026. PubMed · DOI
• Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3). Lancet. 2026. PubMed · DOI
• Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial. JAMA Cardiol. 2026. PubMed · DOI

See his complete investigator listing on PubMed.

Clinical Trials at Encompass Clinical Research

Encompass Clinical Research runs Phase II–IV studies for adults in San Diego County, including studies in obesity, type 2 diabetes, cardiovascular risk, gout, and vaccines. Every study is reviewed by an Institutional Review Board (IRB).

• See the studies enrolling now: encompassresearch.com/studies
• Learn about the site and team: encompassresearch.com · Our People
• Public trial registry: Trials listing Encompass Clinical Research on ClinicalTrials.gov · Trials naming Dr. Audish
• Questions about taking part? See the Encompass FAQ or call (619) 660-9068.

Contact

Find Dr. Audish online: LinkedIn · Doximity · WebMD · Healthgrades · Vitals

This website is for general information only and is not medical advice. Taking part in a clinical trial is voluntary, and eligibility is determined by each study's protocol.